<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/396036</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;396036v4</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;396036</article-id><article-id pub-id-type="other" hwp:sub-type="slug">396036</article-id><article-id pub-id-type="other" hwp:sub-type="atom-slug">396036</article-id><article-id pub-id-type="other" hwp:sub-type="tag">396036</article-id><article-version>1.4</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Neuroscience" hwp:journal="biorxiv"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">Reduction in CD11c<sup>+</sup> microglia correlates with clinical progression in chronic experimental autoimmune demyelination</article-title></title-group><author-notes hwp:id="author-notes-1"><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1"><label>*</label><bold>Corresponding author:</bold> <email hwp:id="email-1">ochechneva@ucdavis.edu</email></corresp></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" hwp:id="contrib-1"><name name-style="western" hwp:sortable="Mayrhofer Florian"><surname>Mayrhofer</surname><given-names>Florian</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-1" hwp:rel-id="aff-2">b</xref></contrib><contrib contrib-type="author" hwp:id="contrib-2"><name name-style="western" hwp:sortable="Dariychuk Zhanna"><surname>Dariychuk</surname><given-names>Zhanna</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-2" hwp:rel-id="aff-2">b</xref></contrib><contrib contrib-type="author" hwp:id="contrib-3"><name name-style="western" hwp:sortable="Zhen Anthony"><surname>Zhen</surname><given-names>Anthony</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-3" hwp:rel-id="aff-2">b</xref></contrib><contrib contrib-type="author" hwp:id="contrib-4"><name name-style="western" hwp:sortable="Daugherty Daniel J."><surname>Daugherty</surname><given-names>Daniel J.</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">a</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-4" hwp:rel-id="aff-2">b</xref></contrib><contrib contrib-type="author" hwp:id="contrib-5"><name name-style="western" hwp:sortable="Bannerman Peter"><surname>Bannerman</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-5" hwp:rel-id="aff-2">b</xref></contrib><contrib contrib-type="author" hwp:id="contrib-6"><name name-style="western" hwp:sortable="Hanson Angela M."><surname>Hanson</surname><given-names>Angela M.</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-6" hwp:rel-id="aff-2">b</xref></contrib><contrib contrib-type="author" hwp:id="contrib-7"><name name-style="western" hwp:sortable="Pleasure David"><surname>Pleasure</surname><given-names>David</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-7" hwp:rel-id="aff-2">b</xref></contrib><contrib contrib-type="author" hwp:id="contrib-8"><name name-style="western" hwp:sortable="Soulika Athena"><surname>Soulika</surname><given-names>Athena</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-8" hwp:rel-id="aff-2">b</xref></contrib><contrib contrib-type="author" hwp:id="contrib-9"><name name-style="western" hwp:sortable="Deng Wenbin"><surname>Deng</surname><given-names>Wenbin</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">a</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-9" hwp:rel-id="aff-2">b</xref></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-10"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-8057-5669</contrib-id><name name-style="western" hwp:sortable="Chechneva Olga V."><surname>Chechneva</surname><given-names>Olga V.</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-3" hwp:rel-id="aff-1">a</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-10" hwp:rel-id="aff-2">b</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">*</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0002-8057-5669"/></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2 xref-aff-1-3"><label>a</label><institution hwp:id="institution-1">Department of Biochemistry and Molecular Medicine</institution>, UC Davis, Sacramento, CA 95817</aff><aff id="a2" hwp:id="aff-2" hwp:rev-id="xref-aff-2-1 xref-aff-2-2 xref-aff-2-3 xref-aff-2-4 xref-aff-2-5 xref-aff-2-6 xref-aff-2-7 xref-aff-2-8 xref-aff-2-9 xref-aff-2-10"><label>b</label><institution hwp:id="institution-2">IPRM, Shriners Hospital for Children</institution>, Sacramento, CA 95817</aff></contrib-group><pub-date pub-type="epub-original" date-type="pub" publication-format="electronic" hwp:start="2021"><year>2021</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2018-08-20T11:45:10-07:00">
    <day>20</day><month>8</month><year>2018</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2021-07-20T21:45:21-07:00">
    <day>20</day><month>7</month><year>2021</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2018-08-20T11:52:13-07:00">
    <day>20</day><month>8</month><year>2018</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2021-07-20T21:50:41-07:00">
    <day>20</day><month>7</month><year>2021</year>
  </pub-date><elocation-id>396036</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2018-08-20"><day>20</day><month>8</month><year>2018</year></date>
<date date-type="rev-recd" hwp:start="2021-07-20"><day>20</day><month>7</month><year>2021</year></date>
<date date-type="accepted" hwp:start="2021-07-20"><day>20</day><month>7</month><year>2021</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">Â© 2021, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2021</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" hwp:id="license-1"><p hwp:id="p-1">This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at <ext-link l:rel="related" l:ref-type="uri" l:ref="http://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" hwp:id="ext-link-1">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link></p></license></permissions><self-uri xlink:href="396036.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/change-list" xlink:role="change-list" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2021/pdf/396036v4.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="396036.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2021/abstracts/396036v4/396036v4.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2021/fulltext/396036v4/396036v4.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">Abstract</title><p hwp:id="p-2">Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease with high variability of clinical symptoms. In most cases MS appears as a relapsing-remitting disease course that at a later stage transitions into irreversible progressive decline of neurologic function. The mechanisms underlying MS progression remain poorly understood. Experimental autoimmune encephalomyelitis (EAE) is an animal model of MS. Here we demonstrate that mice that develop mild EAE after immunization with myelin oligodendrocyte glycoprotein 35-55 are prone to undergo clinical progression around 30 days after EAE induction. EAE progression was associated with reduction in CD11c<sup>+</sup> microglia and dispersed coalescent parenchymal infiltration. We found sex-dependent differences mediated by p38Î± signaling, a key regulator of inflammation. Selective reduction of CD11c<sup>+</sup> microglia in female mice with CD11c-promoter driven <italic toggle="yes">p38Î±</italic> knockout (<italic toggle="yes">KO)</italic> correlated with increased rate of EAE progression. In protected animals, we found CD11c<sup>+</sup> microglia forming contacts with astrocyte processes at the glia limitans and immune cells retained within perivascular spaces. Together, our study provides evidence on the protective role of CD11c<sup>+</sup> microglia in controlling CNS immune cell parenchymal infiltration in autoimmune demyelination.</p></abstract><kwd-group kwd-group-type="author" hwp:id="kwd-group-1"><title hwp:id="title-2">Keywords</title><kwd hwp:id="kwd-1">CD11c<sup>+</sup> microglia</kwd><kwd hwp:id="kwd-2">EAE progression</kwd><kwd hwp:id="kwd-3">CNS infiltration</kwd><kwd hwp:id="kwd-4">p38Î± sexual dimorphism</kwd><kwd hwp:id="kwd-5">glia limitans</kwd></kwd-group><counts><page-count count="31"/></counts><custom-meta-wrap><custom-meta hwp:id="custom-meta-1"><meta-name>special-property</meta-name><meta-value>contains-inline-supplementary-material</meta-value></custom-meta></custom-meta-wrap><custom-meta-wrap>
    <custom-meta hwp:id="custom-meta-2">
      <meta-name>has-earlier-version</meta-name>
      <meta-value>yes</meta-value>
    </custom-meta>
  </custom-meta-wrap></article-meta><notes hwp:id="notes-1"><notes notes-type="competing-interest-statement" hwp:id="notes-2"><title hwp:id="title-3">Competing Interest Statement</title><p hwp:id="p-3">The authors have declared no competing interest.</p></notes><fn-group content-type="summary-of-updates" hwp:id="fn-group-1"><title hwp:id="title-4">Summary of Updates:</title><fn fn-type="update" hwp:id="fn-1"><p hwp:id="p-4">The revised version of our paper focuses on cellular events taking place during EAE progression. We describe immune cells involved in EAE progression and their interaction.</p></fn></fn-group></notes></front><body><sec id="s1" hwp:id="sec-1"><title hwp:id="title-5">Introduction</title><p hwp:id="p-5">Multiple sclerosis (MS) is an autoimmune demyelinating disorder characterized by myelin loss, chronic inflammation, and axonal degeneration. MS is a complex disease with variable outcomes. In 80% of patients, MS appears as a relapsing-remitting form (RRMS), where episodes of neurologic dysfunction are separated by periods of remission (<xref rid="c6" ref-type="bibr" hwp:id="xref-ref-6-1" hwp:rel-id="ref-6">Baecher-Allan et al., 2018</xref>). Within a decade of first diagnosis, the majority of RRMS patients develop progression of clinical deficits (<xref rid="c15" ref-type="bibr" hwp:id="xref-ref-15-1" hwp:rel-id="ref-15">Coret et al., 2018</xref>; <xref rid="c54" ref-type="bibr" hwp:id="xref-ref-54-1" hwp:rel-id="ref-54">Zhang et al., 2015</xref>). The progressive form of MS is refractory to approved RRMS disease-modifying therapies and mechanisms of clinical progression in MS are poorly understood (<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-1" hwp:rel-id="ref-22">Goldschmidt and McGinley, 2021</xref>).</p><p hwp:id="p-6">CD11c<sup>+</sup> microglia are unique microglia that emerge in the CNS during development and injury (<xref rid="c11" ref-type="bibr" hwp:id="xref-ref-11-1" hwp:rel-id="ref-11">Butovsky et al., 2006</xref>; <xref rid="c25" ref-type="bibr" hwp:id="xref-ref-25-1" hwp:rel-id="ref-25">Hagemeyer et al., 2017</xref>; <xref rid="c29" ref-type="bibr" hwp:id="xref-ref-29-1" hwp:rel-id="ref-29">Kamphuis et al., 2016</xref>; <xref rid="c51" ref-type="bibr" hwp:id="xref-ref-51-1" hwp:rel-id="ref-51">Wlodarczyk et al., 2015</xref>; <xref rid="c52" ref-type="bibr" hwp:id="xref-ref-52-1" hwp:rel-id="ref-52">Wlodarczyk et al., 2017</xref>). CD11c<sup>+</sup> microglia have poor antigen presenting capacity (<xref rid="c20" ref-type="bibr" hwp:id="xref-ref-20-1" hwp:rel-id="ref-20">Ford et al., 1995</xref>; <xref rid="c21" ref-type="bibr" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21">Giles et al., 2018</xref>; <xref rid="c24" ref-type="bibr" hwp:id="xref-ref-24-1" hwp:rel-id="ref-24">Greter et al., 2005</xref>; <xref rid="c39" ref-type="bibr" hwp:id="xref-ref-39-1" hwp:rel-id="ref-39">Miller et al., 2007</xref>) and increase in CD11c<sup>+</sup> microglia precedes the onset of experimental autoimmune encephalomyelitis (EAE) an animal model of MS (<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19">Fischer and Reichmann, 2001</xref>; <xref rid="c46" ref-type="bibr" hwp:id="xref-ref-46-1" hwp:rel-id="ref-46">Serafini et al., 2000</xref>). A growing number of evidences suggests that CD11c<sup>+</sup> microglia possess a neuroprotective function in disease. Increase in CD11c<sup>+</sup> microglia reduced clinical disability in EAE (<xref rid="c50" ref-type="bibr" hwp:id="xref-ref-50-1" hwp:rel-id="ref-50">Wlodarczyk et al., 2018</xref>) and alleviated cuprizone-induced demyelination (<xref rid="c45" ref-type="bibr" hwp:id="xref-ref-45-1" hwp:rel-id="ref-45">Sato-Hashimoto et al., 2019</xref>). CD11c<sup>+</sup> microglia were identified on site of amyloid plaques preventing plaque formation in a transgenic model of Alzheimerâs disease (<xref rid="c11" ref-type="bibr" hwp:id="xref-ref-11-2" hwp:rel-id="ref-11">Butovsky et al., 2006</xref>; <xref rid="c29" ref-type="bibr" hwp:id="xref-ref-29-2" hwp:rel-id="ref-29">Kamphuis et al., 2016</xref>; <xref rid="c30" ref-type="bibr" hwp:id="xref-ref-30-1" hwp:rel-id="ref-30">Keren-Shaul et al., 2017</xref>). The function of CD11c<sup>+</sup> microglia in autoimmune demyelination is not well understood.</p><p hwp:id="p-7">Among the key regulators of inflammation is mitogen-activated protein kinase (MAPK) 14 or p38Î± (<xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-1" hwp:rel-id="ref-53">Zarubin and Han, 2005</xref>). p38Î± expression is upregulated in active and chronic lesions in patients with MS (<xref rid="c36" ref-type="bibr" hwp:id="xref-ref-36-1" hwp:rel-id="ref-36">Lock et al., 2002</xref>). p38Î± signaling in CD11c<sup>+</sup> classical dendritic cells (cDC) is required for the differentiation of uncommitted T cells toward T<sub>H</sub>17 phenotype in MS and EAE and involves the IL-6 â STAT3 signaling pathway (<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-1" hwp:rel-id="ref-16">Di Mitri et al., 2015</xref>; <xref rid="c27" ref-type="bibr" hwp:id="xref-ref-27-1" hwp:rel-id="ref-27">Huang et al., 2012</xref>). p38Î± is also required for the reactivation of myelin-primed T<sub>H</sub>17 cells by cDC in adoptive EAE transfer (<xref rid="c27" ref-type="bibr" hwp:id="xref-ref-27-2" hwp:rel-id="ref-27">Huang et al., 2012</xref>). A sex-dependent role of p38Î± in EAE has been reported in myeloid cells, where pharmacological inhibition or myeloid cell knockout of <italic toggle="yes">p38Î±</italic> ameliorated EAE clinical symptoms and inflammation in female mice (<xref rid="c32" ref-type="bibr" hwp:id="xref-ref-32-1" hwp:rel-id="ref-32">Krementsov et al., 2014</xref>). The role of p38Î± in EAE/MS progression remains unknown.</p><p hwp:id="p-8">Here we report that a subgroup of female mice with knockout of p38Î± in CD11c<sup>+</sup> cells (<italic toggle="yes">KO</italic>), initially protected from EAE, develop EAE progression around 30 days post immunization (dpi). We further describe clinical progression in female and male C57BL/6 wild type (<italic toggle="yes">WT</italic>) mice with initially mild EAE. A reduction in CD11c<sup>+</sup> microglia and dispersed coalescent parenchymal infiltration were evident at EAE progression in both conditions. In animals that did not develop EAE progression, we found CD11c<sup>+</sup> microglia in association with astrocyte processes and vasculature. Together, our data indicate a protective role of CD11c<sup>+</sup> microglia in controlling immune cell parenchymal infiltration during chronic autoimmune demyelination.</p></sec><sec id="s2" hwp:id="sec-2"><title hwp:id="title-6">Materials and Methods</title><sec id="s2a" hwp:id="sec-3"><title hwp:id="title-7">Animals</title><p hwp:id="p-9">Female and male C57BL/6 <italic toggle="yes">WT</italic> (JAX stock #000664), <italic toggle="yes">p38Î±</italic><sup>fl/fl</sup> (<italic toggle="yes">Floxed</italic>) ([B6.129-<italic toggle="yes">Mapk14</italic>&lt;tm1.2Otsu], Riken #RBRC02192), and <italic toggle="yes">p38Î±</italic><sup>ÎCD11c</sup> (<italic toggle="yes">KO</italic>) mice 12 weeks old were used to study EAE progression. Mice carrying the <italic toggle="yes">p38Î± floxed</italic> allele were crossed with mice expressing Cre recombinase under the CD11c promoter ([C57BL/6J-Tg(<italic toggle="yes">Itgax</italic>-cre-EGFP)4097Ach/J], JAX stock #007567). Offsprings were genotyped for the homologous presence of <italic toggle="yes">p38Î± floxed</italic> allele and <italic toggle="yes">Cre</italic> insert as described earlier (<xref rid="c35" ref-type="bibr" hwp:id="xref-ref-35-1" hwp:rel-id="ref-35">Lo et al., 2014</xref>). Animals were maintained in accordance with the NIH Guide for the Care and Use of Laboratory Animals. Experimental protocols were approved by the Institutional Animal Care and Use Committee at the University of California, Davis.</p></sec><sec id="s2b" hwp:id="sec-4"><title hwp:id="title-8">EAE induction</title><p hwp:id="p-10">EAE was induced in female and male mice at the age of 12 weeks as described earlier with some modifications (<xref rid="c13" ref-type="bibr" hwp:id="xref-ref-13-1" hwp:rel-id="ref-13">Chechneva et al., 2011</xref>). In brief, mice were injected subcutaneously at two flank sites with an emulsion of myelin oligodendrocyte glycoprotein peptide fragment that spans amino acids 35-55 (MOG) (New England Peptide) in incomplete Freundâs adjuvant supplemented with 500 Âµg Mycobacterium tuberculosis H37Ra (Difco). Our previously described EAE model with MOG prepared by sonication causes severe EAE in C57BL/6 mice (<xref rid="c13" ref-type="bibr" hwp:id="xref-ref-13-2" hwp:rel-id="ref-13">Chechneva et al., 2011</xref>). Sonication changes biochemical composition of MOG epitopes and/or Mycobacterium tuberculosis causing an enhanced immune response (<xref rid="c1" ref-type="bibr" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">Adelmann et al., 1995</xref>). In <italic toggle="yes">KO</italic> mice, sonicated MOG causes mild EAE. EAE in <italic toggle="yes">KO</italic> and <italic toggle="yes">Floxed</italic> control mice was induced by MOG (300 Î¼g) emulsion prepared by quick sonication (3Ã5 sec on ice). To induce mild EAE in <italic toggle="yes">WT</italic> mice, MOG (150 Î¼g) was homogenized with 2 syringes connected by a stopcock (twice 10 min with 3 h interval on ice). Emulsion was kept in the dark at 4Â°C between mixing and before preparing into individual doses in syringes. All mice received 200 ng of pertussis toxin (PTX) (List Biological Labs) intraperitoneally (i. p.) on day 0 and 2. The severity of clinical symptoms was evaluated using following neurologic scoring for EAE: 0 - no deficit; 0.5 - mild loss of tail tone; 1 - complete loss of tail tone; 1.5 - mildly impaired righting reflex; 2 - abnormal gait (ataxia) and/or impaired righting reflex; 2.5-single hind limb paresis and ataxia; 3 - double hind limb paresis; 3.5 - single limb paralysis and paresis of second limb / paresis of both hind limbs and weakness of front limbs; 4 - full paralysis of two limbs; 4.5 - hind limb paralysis with hind body paresis; 5 â moribund or death. Animals were monitored and scored daily. At 30 dpi, <italic toggle="yes">WT</italic> mice were organized in three groups, according to clinical phenotype. Mild EAE was defined by chronic mild clinical symptoms throughout EAE course, ranging from loss of tail tone to abnormal gait/paresis (maximum score 3). Severe EAE included animals with minimal recovery from EAE peak and scores of 3.5 (single limb paralysis) and above throughout chronic EAE course. EAE progression was identified by transition from mild to severe disease around 30 dpi with an acute increase in clinical score by 1-2.5 points.</p></sec><sec id="s2c" hwp:id="sec-5"><title hwp:id="title-9">Histology and pathological scoring</title><p hwp:id="p-11">Histological analysis was performed as described earlier (<xref rid="c13" ref-type="bibr" hwp:id="xref-ref-13-3" hwp:rel-id="ref-13">Chechneva et al., 2011</xref>). Briefly, mice were anesthetized with isoflurane and perfused with ice cold phosphate buffered saline (PBS). Lumbar spinal cords were dissected, cryopreserved in 20% sucrose, embedded in OCT compound and cut in 15 Âµm sections on the cryostat. For Luxol Fast Blue (LFB) staining, sections were incubated with 0.1% LFB solution at 60Â°C for 16 h followed by differentiation with 0.05% lithium carbonate and co-stained with 0.1% Cresyl Violet (Nissl). Slides were mounted using Cytoseal-60 medium and images were acquired on Keyence BZ-9000 microscope. For pathological assessment, for each animal, six sections of the lumbar spinal cord in the interval of 180 Âµm were scored by blinded investigator for infiltration, vacuolation caused by swollen axon sheaths and demyelination. We used following scoring system: 0 - absence of lesion and infiltration; 1 - not clearly visible lesions and infiltration, 2 â clearly visible lesions and infiltration, 3 â prominent multifocal lesions and infiltration, 4 â marked continuous lesions and infiltration (<xref rid="c3" ref-type="bibr" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">Anderson et al., 2011</xref>).</p></sec><sec id="s2d" hwp:id="sec-6"><title hwp:id="title-10">Immunohistochemistry</title><p hwp:id="p-12">For immunostaining, sections were washed with PBS to remove residues of OCT compound. Nonspecific binding of antibodies was blocked using 10% normal serum in 0.2% Triton-X in PBS. Samples were incubated with rabbit anti-Iba1 (ionized calcium binding adaptor molecule 1; 1:500; Wako 019-19741), rabbit anti-CD4 (1:200; Abcam ab183685), rat anti-CD4 (1:100; BD Pharmingen 550280), rat anti-CD31 (1:200; Abcam ab56299), chicken anti-GFP (1:500, Abcam ab13970), rabbit anti-CCL2 (1:200, Millipore AB1834P), DyLight 594-Lectin (1:200, Vector Laboratories DL-1177) overnight at 4 Â°C. Fluorophore- conjugated secondary antibodies Alexa Fluor 488, 555 or 647 (1:1000; Life Technologies) were used to detect primary antibody. Slides were mounted using DAPI Fluoromount-G (SouthernBiotech). Images were acquired on Nikon Eclipse 90i (A1) microscope. For DAB staining, sections were treated with 1% H<sub>2</sub>O<sub>2</sub> to stop endogenous peroxidase activity before incubation with blocking serum. Samples were incubated with primary antibody. HRP- conjugated secondary antibody was used to detect primary antibody. Positive signal was visualized using ImmPACT DAB Peroxidase substrate kit (Vector labs). Slides were mounted using Cytoseal-60 medium and images were acquired on Keyence BZ-9000 microscope. For fluorescent and DAB staining negative controls omitting primary antibody were performed. Images were processed using Adobe Photoshop CC.</p></sec><sec id="s2e" hwp:id="sec-7"><title hwp:id="title-11">Flow cytometry analysis</title><p hwp:id="p-13">Mice were deeply anesthetized and transcardially perfused with ice-cold PBS for 3 min with a flow rate at 3 ml/min. All steps were performed on ice (4Â°C), unless otherwise stated. Brain and spinal cord were dissected and placed in ice-cold HBSS (Hankâs Balanced Salt Solution) in 2.5 cm culture dish. For tissue digestion, papain resulted in a higher cell yield compared to collagenase. However, we found that papain digestion resulted in the loss of CD11c expression on the cell surface. Therefore, CNS tissue for all FACS experiments were digested using collagenase. Collagenase D (Roche) 1 mg/ml and 0.02 mg/ml with 100 U/ml DNAse I (Worthington) were added to each dish (final concentration), tissue was chopped into â¼1-2 mm<sup>3</sup> pieces and incubated while shaking at 100 rpm at 37 Â°C with 5% CO<sub>2</sub> for 20 min. Enzymatic activity was blocked by EDTA at final concentration 2 mM. Tissue was homogenized in Dounce homogenizer (5-8 strokes) and cell suspension was passed through a 100 Âµm cell strainer (Corning) in 50 ml falcon tubes. Cells were collected at 350 x g for 5 min at 4Â°C, resuspended in 37% Percoll (GE Healthcare), transferred to 15 ml falcon tubes and centrifuged at 500 x g for 15 min with 0 brake at 4Â°C. Cell myelin layer containing cell debris was aspirated. Cell pellet was resuspended in cold 0.5 ml RBC lysis buffer (Biolegend, 420301), transferred to 15 ml falcon tubes and incubated for 30 sec. 5 ml PBS was added before centrifugation at 350 x g at 4Â°C for 5 min. Cells were resuspended in FACS buffer (PBS plus 1% BSA and 0.1% sodium azide), counted using hemocytometer and transferred to staining plates (Fisher Scientific, 12565502). Following 15 min of Fc receptors blocking with CD16/CD32 antibody (BD Pharmingen), cells were stained with fluorophore-conjugated antibodies: CD11b BV605 (1:200, clone M1/70, Biolegend), CD45 PerCP-Cy5.5 (1:200, clone 30-F11, Biolegend), Ly6G APC-Cy7 (1:200, clone 1A8, BD Biosciences), CD11c FITC (1:100, clone N418, Biolegend), CD11c APC (1:100, clone N418, Biolegend) for 30-60 min. Cells were washed twice with FACS buffer and once with PBS to remove residues of BSA, then incubated with dead cell dye, Zombie red (1:1000 in PBS, Biolegend) for 15 min. After washing, cells were analyzed on Attune NxT Acoustic Focusing Cytometer (Life Technologies). For cytokine detection, cells were counted and incubated in RPMI-1640 medium supplemented with 10% FBS, 2 mM glutamax, 1 mM sodium pyruvate, 0.1 mM NEAA, 100 U penicillin/streptomycin, 50 ÂµM Î²-ME with Golgi plug (BD Biosciences, 555029) for 1 h at 37<sup>0</sup>C with 5% CO<sub>2</sub>. Phorbol 12-myristate 13-acetate (PMA, 50 ng/ml final concentration) and ionomycin (750 ng/ml final concentration) were added to incubate for 4-5 h at 37Â°C. Fc receptors were blocked as described above and cells were stained with CD3e FITC (1:200, clone 145-2C11, BD Pharmingen) or CD3e PE-Cy7 (1:200, clone 145-2C11, BD Pharmingen). Dead cells were labeled using Violet fluorescence reactive dye for 20 min (1:1000, ThermoFisher, Cat# L34963). Cells were fixed for 15 min using BD Cytofix/Cytoperm reagent (BD Biosciences, 554722). After washing with BD Perm/Wash (BD Biosciences, 554723) twice, cells were incubated overnight at 4Â°C with IFN-Î³ APC (1:25, Clone XMG1.2, Biolegends) and IL-17 PE (1:50, Clone TC11-18H10, BD Pharmingen) in Perm/Wash buffer. Cells were washed and resuspended in FACS buffer for analysis on Attune NxT Acoustic Focusing Cytometer (Life Technologies). Unstained cells, single stain controls and stained AbC Total Antibody Compensation beads (Thermo Fisher, A10497) were used for each experiment to determine compensation parameters. For isotype control of fluorescence minus one, antibody was substituted by fluorophore-conjugated isotype control. Acquired data were analyzed using FlowJo software (TreeStar). To define populations of CD11c<sup>+</sup> microglia, we found gating on CD11b<sup>+</sup> and CD45<sup>+</sup> cells from the pool of CD11c<sup>+</sup> cells was more accurate than gating of CD11c<sup>+</sup> cells from CD11b<sup>+</sup>CD45<sup>low</sup> due to the lack of clear separation of macrophages/monocytes from microglia within CD11b<sup>+</sup>CD45<sup>int</sup> population. Absolute numbers of cell types isolated from the CNS was determined by multiplying the total number of live cells to the proportion of the cell type acquired by flow cytometer. Quantitative data were presented in absolute numbers.</p></sec><sec id="s2f" hwp:id="sec-8"><title hwp:id="title-12">Proliferation assay of CD11c<sup>+</sup> cells</title><p hwp:id="p-14">EdU is a thymidine nucleoside analog that incorporates into DNA during S-phase of the cell cycle. To label proliferating cells, animals were pulsed twice with 12 mg/kg EdU intraperitoneal injection in 12 h interval. 24 h after the first injection, animals were deeply anesthetized and perfused with ice-cold PBS. Brain and spinal cord were dissected, and cells were isolated as described above. Following steps were performed on ice (4Â°C), unless otherwise stated. Fc receptors were blocked with CD16/CD32 antibody (BD Pharmingen) for 15 min and cells were stained with fluorophore-conjugated antibodies: CD11b BV605 (1:200, clone M1/70, Biolegend), CD45 PerCP-Cy5.5 (1:200, clone 30-F11, Biolegend) and CD11c APC (1:100, clone N418, Biolegend) for 30 min. Zombie violet (1:1000, Biolegend) was used to label dead cells. Cells were then fixed with 4% PFA for 15 min at RT. After washing with 1% BSA in PBS, cells were permeabilized with saponin-based permeabilization and wash reagent (Invitrogen, Click-iT Plus EdU Kit) for 15 min at RT. Residues of permeabilization buffer were removed by centrifugation at 350 x g for 5 min. EdU was detected by incubation with freshly prepared Click-iT cocktail containing Tris-HCl (100 mM, pH 7.6), 2 mM CuSO<sub>4</sub>, 2.5 ÂµM Sulfo-Cy3 Azide (Limiprobe) and 100 mM ascorbic acid for 15 min at RT in the dark. Cells were washed with FACS buffer and analyzed on Attune NxT Acoustic Focusing Cytometer (Life Technologies). For Cy3 single stain compensation control we used cells isolated from bone marrow. Proliferation rate was determined as the percentage of EdU<sup>+</sup> cells within cell populations.</p></sec><sec id="s2g" hwp:id="sec-9"><title hwp:id="title-13">p38 kinase activity</title><p hwp:id="p-15">p38 MAPK activity was assessed by quantifying phospho-p38 MAPK expression levels. <italic toggle="yes">KO</italic> and <italic toggle="yes">Floxed</italic> female and male mice were intraperitoneally injected with 3 mg/kg LPS (O111:B4, Sigma). 24 h after, mice were deeply anesthetized and spleens were isolated, chopped in ice-cold HBSS, and enzymatically digested for 20 min at 37Â°C. Digested tissue was passed through a 70 Âµm cell strainer into 50 ml falcon tubes using the backside of 1 ml syringe. Cells were pelleted by centrifugation at 350 x g at 4Â°C for 5 min and resuspended in ice-cold 1 ml RBC lysis buffer. After washing and centrifugation, cells were resuspended in MACS buffer (PBS with 0.5% BSA and 2 mM EDTA) and counted using hematocytometer. After centrifugation, cells were resuspended and incubated in MACS buffer containing Fc blocker and CD11c MicroBeads (Miltenyi Biotec) according to manufacturer instruction. CD11c<sup>+</sup> cells were isolated using LS columns (Miltenyi Biotec, Cat# 130-108-338), pelleted and processed for staining on ice (4Â°C). After Fc receptor blocking with CD16/CD32 antibody (BD Pharmingen), cells were incubated with fluorophore-conjugated antibodies CD11b BV605 (1:200, clone M1/70, Biolegend) and CD11c APC (1:100, clone N418, Biolegend) for 30-60 min. After washing, cells were incubated with dead cell dye Zombie red (1:1000 in PBS, Biolegend) for 15 min. Cells were fixed for 15 min using BD Cytofix/Cytoperm reagent. After washing with BD Perm/Wash, cells were incubated overnight with phospho-p38 MAPK PE (Thr180/Tyr182 (3D7), 1:50, Cell Signaling). Cells were analyzed on Attune NxT Acoustic Focusing Cytometer (Life Technologies). Unstained cells, single stain controls, stained AbC Total Antibody Compensation beads and isotype controls were used for each experiment. Acquired data were analyzed using FlowJo software (TreeStar).</p></sec><sec id="s2h" hwp:id="sec-10"><title hwp:id="title-14">RNA isolation and qPCR</title><p hwp:id="p-16">RNA transcription levels of CCL2 in the lumbar spinal cord was analyzed using qPCR as described earlier (<xref rid="c13" ref-type="bibr" hwp:id="xref-ref-13-4" hwp:rel-id="ref-13">Chechneva et al., 2011</xref>). Briefly, mice were anesthetized and transcardially perfused with ice-cold PBS. Lumbar spinal cords were dissected and stored separately in liquid nitrogen. Total RNA was isolated from spinal cord tissue using Direct-zol RNA MiniPrep Kit (Zymo Research) following the manufacturer protocol. RNA at purity OD<sub>260/280</sub> ratio between 1.8 and 2.0 was reverse-transcribed to cDNA using Multiscribe reverse transcriptase (Applied Biosystems). TaqMan gene expression assay (Applied Biosystems) was used for <italic toggle="yes">CCL2</italic> (Mm00441242_m1). All experimental samples were normalized to the expression level of <italic toggle="yes">GAPDH</italic> (4352339E Applied Biosystems). Relative quantification of fold-change was performed by applying the 2<sup>-ÎÎ</sup>CT method and comparing Cp values of individual mice (<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-1" hwp:rel-id="ref-34">Livak and Schmittgen, 2001</xref>).</p></sec><sec id="s2i" hwp:id="sec-11"><title hwp:id="title-15">Statistics</title><p hwp:id="p-17">Statistical analysis was performed using GraphPad Prism 7.5. The numbers of animals per group used for each study are shown in the figures as individual dots or indicated in the figure legend. EAE clinical scores were pooled from four independent EAE experiments and evaluated for statistical significance using Two-way ANOVA with Sidakâs multiple comparisons test. One-way ANOVA with Tukeyâs post hoc test was used to analyze data in <xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-1" hwp:rel-id="T1">Table 1</xref>. Two group experiments were analyzed using Studentâs t-test. Experiments with three and more groups were analyzed using One-way ANOVA with Tukeyâs post hoc test. In all figures, data are represented as mean Â± s.e.m. In all cases, probability values less than 0.05 were considered statistically significant. Images were assembled using Adobe Illustrator CC.</p><table-wrap id="tbl1" orientation="portrait" position="float" hwp:id="T1" hwp:rev-id="xref-table-wrap-1-1 xref-table-wrap-1-2 xref-table-wrap-1-3 xref-table-wrap-1-4"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;396036v4/TBL1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T1</object-id><object-id pub-id-type="publisher-id">tbl1</object-id><label>Table 1.</label><caption hwp:id="caption-1"><title hwp:id="title-16">Clinical assessment of EAE in <italic toggle="yes">p38Î± Floxed</italic> and CD11c promoter-driven <italic toggle="yes">p38Î± KO</italic> female and male mice</title></caption><graphic xlink:href="396036v4_tbl1" position="float" orientation="portrait" hwp:id="graphic-1"/></table-wrap></sec></sec><sec id="s3" hwp:id="sec-12"><title hwp:id="title-17">Results</title><sec id="s3a" hwp:id="sec-13"><title hwp:id="title-18">Female mice with knockout of <italic toggle="yes">p38Î±</italic> in CD11c<sup>+</sup> cells are susceptible to EAE progression</title><p hwp:id="p-18">We induced EAE in <italic toggle="yes">KO</italic> and <italic toggle="yes">Floxed</italic> female and male mice and followed EAE clinical symptoms for 60 days. As reported earlier, <italic toggle="yes">Floxed</italic> mice developed chronic severe disease, while <italic toggle="yes">KO</italic> mice were protected and initially displayed mild EAE (<xref rid="c27" ref-type="bibr" hwp:id="xref-ref-27-3" hwp:rel-id="ref-27">Huang et al., 2012</xref>; <xref rid="c32" ref-type="bibr" hwp:id="xref-ref-32-2" hwp:rel-id="ref-32">Krementsov et al., 2014</xref>) (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-1" hwp:rel-id="F1">Fig. 1A</xref>, <xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-2" hwp:rel-id="T1">Table 1</xref>). EAE onset and peak were delayed in <italic toggle="yes">KO</italic> females compared to <italic toggle="yes">KO</italic> males (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-2" hwp:rel-id="F1">Fig. 1A</xref>, <xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-3" hwp:rel-id="T1">Table 1</xref>). At 30 dpi, 58% of <italic toggle="yes">KO</italic> females underwent clinical progression and transition from mild to severe disease with a sudden increase in clinical score by 1-2.5 points (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-3" hwp:rel-id="F1">Fig. 1A</xref>, <xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-4" hwp:rel-id="T1">Table 1</xref>). No progression of EAE clinical symptoms was observed in <italic toggle="yes">KO</italic> males.</p><fig id="fig1" position="float" fig-type="figure" orientation="portrait" hwp:id="F1" hwp:rev-id="xref-fig-1-1 xref-fig-1-2 xref-fig-1-3 xref-fig-1-4 xref-fig-1-5 xref-fig-1-6 xref-fig-1-7 xref-fig-1-8 xref-fig-1-9 xref-fig-1-10 xref-fig-1-11 xref-fig-1-12"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;396036v4/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>Fig. 1.</label><caption hwp:id="caption-2"><title hwp:id="title-19">Female mice with knockout of <italic toggle="yes">p38Î±</italic> in CD11c<sup>+</sup> cells are susceptible to EAE progression with dispersed parenchymal infiltration.</title><p hwp:id="p-19">(A) <italic toggle="yes">p38Î± Floxed</italic> control and CD11c promoter-driven <italic toggle="yes">KO</italic> female and male mice were immunized with MOG prepared by sonication. EAE clinical scores were monitored daily for 60 dpi. Data are representative of four independent experiments with n = 41 for <italic toggle="yes">Floxed</italic> males, n = 32 for <italic toggle="yes">Floxed</italic> females, n = 47 for <italic toggle="yes">KO</italic> males, n = 23 for <italic toggle="yes">KO</italic> females with progression, and n = 17 for <italic toggle="yes">KO</italic> females with chronic mild EAE. <italic toggle="yes">P</italic> values were determined by two-way ANOVA with Sidakâs multiple comparisons test. (B) Representative images of Luxol-Nissl staining, CD4<sup>+</sup> T cells and Iba1<sup>+</sup> macrophages/microglia in the lumbar spinal cord at 30 dpi. Clusters of immune cells at the meninges and perivascular areas in <italic toggle="yes">KO</italic> males (arrows). Scale bar 100 Âµm. (C) Pathological scoring of chronic EAE based on the severity of infiltration and demyelination. Data are representative of two independent experiments.</p><p hwp:id="p-20">(D) Quantification of CD4<sup>+</sup> T cells in the white matter parenchyma. (E-G) Flow cytometry analysis of CD45<sup>+</sup> cells, Ly6G<sup>+</sup> neutrophils, CD11b<sup>+</sup>CD45<sup>hi</sup> macrophages/monocytes and CD11b<sup>+</sup>CD45<sup>lo</sup> microglia isolated from the brain and spinal cord at 30 dpi. (H-K) Quantification of CD45<sup>+</sup> cells, Ly6G<sup>+</sup> neutrophils, CD11b<sup>+</sup>CD45<sup>hi</sup> macrophages/monocytes and CD11b<sup>+</sup>CD45<sup>lo</sup> microglia. Data are representative of three independent experiments. Each point represents an individual animal. P values were determined by One-way ANOVA with Tukeyâs post hoc test. dpi, days post immunization; F, females; M, males; <italic toggle="yes">KO</italic>, knockout; Prog, progression.</p></caption><graphic xlink:href="396036v4_fig1" position="float" orientation="portrait" hwp:id="graphic-2"/></fig><p hwp:id="p-21">We analyzed EAE pathology at 30 dpi in the lumbar spinal cord of <italic toggle="yes">KO</italic> and <italic toggle="yes">Floxed</italic> mice. In progressed <italic toggle="yes">KO</italic> females, we found dispersed parenchymal infiltration, demyelination, and CD4<sup>+</sup> T cells and Iba1<sup>+</sup> macrophages/reactive microglia densely scattered throughout the white matter parenchyma (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-4" hwp:rel-id="F1">Fig. 1B-D</xref>). In contrast, in <italic toggle="yes">KO</italic> males we found a distinct pattern of immune cell infiltration where peripheral immune cells clustered at perivascular areas and the meninges, and CD4<sup>+</sup> T cells had rare appearance in the parenchyma (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-5" hwp:rel-id="F1">Fig. 1B-D</xref>). T cells that invaded CNS parenchyma in progressed <italic toggle="yes">KO</italic> females were enriched in INF-Î³<sup>+</sup> T<sub>H</sub>1 population (Supplementary Fig. 1A-D). We found an increase in transcription level of <italic toggle="yes">IL-12b</italic> (also known as <italic toggle="yes">IL-12p40</italic>), a driver of T<sub>H</sub>1 cell differentiation (<xref rid="c8" ref-type="bibr" hwp:id="xref-ref-8-1" hwp:rel-id="ref-8">Balashov et al., 1997</xref>) (Supplementary Fig. 1E). In <italic toggle="yes">KO</italic> females with mild EAE that did not transition to EAE progression we observed minor immune cell infiltration (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-6" hwp:rel-id="F1">Fig. 1B-D</xref>). In <italic toggle="yes">Floxed</italic> mice sustained parenchymal infiltration and demyelination corresponding to chronic severe disease state were evident (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-7" hwp:rel-id="F1">Fig. 1B-D</xref>).</p><p hwp:id="p-22">We further analyzed CNS infiltrates using flow cytometry. CD45<sup>+</sup> cells were significantly increased in the brain and spinal cord of progressed <italic toggle="yes">KO</italic> females compared to <italic toggle="yes">KO</italic> males and mild non-progressed <italic toggle="yes">KO</italic> females (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-8" hwp:rel-id="F1">Fig. 1E, 1H</xref>). CD45<sup>+</sup> cells included Ly6G<sup>+</sup> neutrophils (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-9" hwp:rel-id="F1">Fig. 1F, 1I</xref>) and CD11b<sup>+</sup>CD45<sup>hi</sup> macrophages/monocytes (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-10" hwp:rel-id="F1">Fig. 1G, 1J</xref>). <italic toggle="yes">KO</italic> females without progression had low numbers of infiltrating immune cells (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-11" hwp:rel-id="F1">Fig. 1E-J</xref>). There were no significant differences in the numbers of CD11b<sup>+</sup>CD45<sup>lo</sup> microglia between groups (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-12" hwp:rel-id="F1">Fig. 1G, 1K</xref>). We conclude that peripheral immune cell infiltration contributes to EAE progression in <italic toggle="yes">KO</italic> female mice.</p></sec><sec id="s3b" hwp:id="sec-14"><title hwp:id="title-20">Reduction in CD11c<sup>+</sup> microglia in <italic toggle="yes">KO</italic> female mice</title><p hwp:id="p-23">CD11c<sup>+</sup> cells play an active role in the pathogenesis of MS and EAE (<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-2" hwp:rel-id="ref-16">Di Mitri et al., 2015</xref>; <xref rid="c21" ref-type="bibr" hwp:id="xref-ref-21-2" hwp:rel-id="ref-21">Giles et al., 2018</xref>; <xref rid="c27" ref-type="bibr" hwp:id="xref-ref-27-4" hwp:rel-id="ref-27">Huang et al., 2012</xref>; <xref rid="c32" ref-type="bibr" hwp:id="xref-ref-32-3" hwp:rel-id="ref-32">Krementsov et al., 2014</xref>; <xref rid="c38" ref-type="bibr" hwp:id="xref-ref-38-1" hwp:rel-id="ref-38">Merad et al., 2013</xref>; <xref rid="c41" ref-type="bibr" hwp:id="xref-ref-41-1" hwp:rel-id="ref-41">Mundt et al., 2019</xref>). Using flow cytometry, we found an increase in CD11c<sup>+</sup> cells driven by an increase in the CD11c<sup>+</sup>CD11b<sup>+</sup>CD45<sup>hi</sup> moDC in the brain and spinal cord of progressed <italic toggle="yes">KO</italic> females (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-1" hwp:rel-id="F2">Fig. 2A-D</xref>). An increase in the number of CD11c<sup>+</sup>CD11b<sup>-</sup>CD45<sup>hi</sup> cDC was found in progressed compared to non-progressed <italic toggle="yes">KO</italic> females with mild EAE, reflecting the disease pathology (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-2" hwp:rel-id="F2">Fig. 2E</xref>). Surprisingly, a significant reduction in CD11c<sup>+</sup>CD11b<sup>+</sup>CD45<sup>lo</sup> or CD11c<sup>+</sup> microglia was found in progressed and non-progressed <italic toggle="yes">KO</italic> females (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-3" hwp:rel-id="F2">Fig. 2C, F</xref>). Gating on CD11c<sup>+</sup> microglia from the pool of CD11b<sup>+</sup>CD45<sup>lo</sup> cells resulted in a similar outcome (Supplementary Fig. 2A-B).</p><fig id="fig2" position="float" fig-type="figure" orientation="portrait" hwp:id="F2" hwp:rev-id="xref-fig-2-1 xref-fig-2-2 xref-fig-2-3 xref-fig-2-4 xref-fig-2-5"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;396036v4/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>Fig. 2.</label><caption hwp:id="caption-3"><title hwp:id="title-21">Reduction in CD11c<sup>+</sup> microglia at EAE progression in <italic toggle="yes">KO</italic> female mice.</title><p hwp:id="p-24">(A) Flow cytometry analysis of CD11c<sup>+</sup> cells isolated from the brain and spinal cord of <italic toggle="yes">Floxed</italic> and <italic toggle="yes">KO</italic> male and female mice at 30 dpi. (B) Quantification of CD11c<sup>+</sup> cells. (C) Flow cytometry analysis of cDC, moDC and CD11c<sup>+</sup> microglia differentiated by expression of CD45 and CD11b. (D-F) Quantification of moDC, cDC, and CD11c<sup>+</sup> microglia. (G) MOG-PTX immunized <italic toggle="yes">p38Î± Floxed</italic> control and CD11c promoter-driven <italic toggle="yes">KO</italic> female and male mice without EAE clinical symptoms at 30 dpi were injected with 12 mg/kg EdU twice in 12 h interval. EdU<sup>+</sup> cells were analyzed 24 h after first injection. Proliferative response was determined as percentage of EdU<sup>+</sup> cells of cell population. (H) Quantification of cDC. (I) Proliferative response of cDC. (J) Quantification of moDC. (K) Proliferative response of moDC. (L) Quantification of CD11c<sup>+</sup> microglia. (M) Proliferative response of CD11c<sup>+</sup> microglia. Data are representative of three independent experiments on immune cell quantification and two independent experiments on proliferative response. Each point represents an individual animal. <italic toggle="yes">P</italic> values were determined by One-way ANOVA with Tukeyâs post hoc test. dpi, days post immunization; F, females; <italic toggle="yes">KO</italic>, knockout; M, males; Prog, progression.</p></caption><graphic xlink:href="396036v4_fig2" position="float" orientation="portrait" hwp:id="graphic-3"/></fig><p hwp:id="p-25">In EAE, microglia increase in numbers by proliferation (<xref rid="c2" ref-type="bibr" hwp:id="xref-ref-2-1" hwp:rel-id="ref-2">Ajami et al., 2011</xref>; <xref rid="c28" ref-type="bibr" hwp:id="xref-ref-28-1" hwp:rel-id="ref-28">Jordao et al., 2019</xref>). To test whether proliferation of CD11c<sup>+</sup> microglia is dependent on p38 signaling we compared cell proliferation in MOG-PTX immunized <italic toggle="yes">Floxed</italic> and <italic toggle="yes">KO</italic> mice that did not develop clinical symptoms by 30 dpi. Under this condition, we found an increase in numbers of CNS associated CD45<sup>+</sup> immune cells, indicating a primed immune response (Supplementary Fig. 3A). The numbers and proliferation rates of CNS associated cDC or moDC were not affected by knockout of <italic toggle="yes">p38Î±</italic> (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-4" hwp:rel-id="F2">Fig. 2G-K</xref>). However, we found that numbers and proliferation rate of CD11c<sup>+</sup> microglia were decreased in <italic toggle="yes">KO</italic> female compared to <italic toggle="yes">KO</italic> male mice (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-5" hwp:rel-id="F2">Fig. 2G, 2L-M</xref>). Proliferation rate of macrophages/monocytes or total microglia were not different between groups (Supplementary Fig. 3B-D). To demonstrate efficiency of <italic toggle="yes">p38Î±</italic> knockout, expression of the activated form of p38 MAPK, phospho-p38 MAPK (p-p38), was examined in splenocytes after LPS stimulation. Reduced expression of p-p38 was found in CD11c<sup>+</sup> splenocytes in <italic toggle="yes">KO</italic> female and <italic toggle="yes">KO</italic> male mice compared to <italic toggle="yes">Floxed</italic> control (Supplementary Fig. 3E-F). We conclude that EAE progression in <italic toggle="yes">KO</italic> female mice is associated with p38Î±-dependent reduction in CD11c<sup>+</sup> microglia.</p></sec><sec id="s3c" hwp:id="sec-15"><title hwp:id="title-22">Reduction in CD11c<sup>+</sup> microglia occurs at EAE progression in <italic toggle="yes">WT</italic> mice</title><p hwp:id="p-26">To study EAE progression in <italic toggle="yes">WT</italic> mice, we induced EAE in C57BL/6 mice with MOG prepared by syringe emulsification. This EAE model resulted in three distinct EAE phenotypes: mild (42%), severe (31%) and initially mild with progression around 30 dpi (27%) (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-1" hwp:rel-id="F3">Fig. 3A</xref>, <xref rid="tbl2" ref-type="table" hwp:id="xref-table-wrap-2-1" hwp:rel-id="T2">Table 2</xref>). We compared the pathology between different EAE phenotypes at 30 dpi and EAE peak. Histological analysis revealed dispersed coalescent infiltration of the spinal cord white matter at EAE progression compared to focal infiltrates found at EAE peak (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-2" hwp:rel-id="F3">Fig. 3B</xref>). A diffuse scattering of immune cells in the parenchyma with lower density than at EAE progression was observed in chronic severe EAE (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-3" hwp:rel-id="F3">Fig. 3B</xref>). In all EAE groups the vast majority of parenchymal immune cells were Iba1<sup>+</sup> macrophages/reactive microglia (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-4" hwp:rel-id="F3">Fig. 3C</xref>). EAE progression was associated with an increase in T<sub>H</sub>1 and T<sub>H</sub>17 cells compared to mild and severe EAE (Supplementary Fig. 4A-D). Flow cytometry showed a significant increase in CD45<sup>+</sup> cells including neutrophils, macrophages/monocytes, cDC and moDC at EAE peak compared to all chronic EAE groups (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-1" hwp:rel-id="F4">Fig. 4A-K</xref>). Increase in neutrophils, macrophages/monocytes, cDC and moDC was evident at EAE progression compared to mild and severe EAE (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-2" hwp:rel-id="F4">Fig. 4A-K</xref>). The numbers of CD11b<sup>+</sup>CD45<sup>lo</sup> microglia were consistently increased in all EAE groups compared to healthy control (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-3" hwp:rel-id="F4">Fig. 4C, 4L</xref>). Notable, EAE progression was associated with a significant reduction in CD11c<sup>+</sup> microglia (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-4" hwp:rel-id="F4">Fig. 4E, 4M</xref>, Supplementary Fig. 4E-F). There were no sex-dependent differences within immune cell populations between experimental conditions in <italic toggle="yes">WT</italic> mice. We conclude that clinical progression during chronic EAE is associated with dispersed parenchymal infiltration and involves reduction in CD11c<sup>+</sup> microglia.</p><fig id="fig3" position="float" fig-type="figure" orientation="portrait" hwp:id="F3" hwp:rev-id="xref-fig-3-1 xref-fig-3-2 xref-fig-3-3 xref-fig-3-4"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;396036v4/FIG3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F3</object-id><object-id pub-id-type="publisher-id">fig3</object-id><label>Fig. 3.</label><caption hwp:id="caption-4"><title hwp:id="title-23">Diffuse parenchymal infiltration at EAE progression in <italic toggle="yes">WT</italic> mice.</title><p hwp:id="p-27">EAE was induced in C57BL/6 mice with MOG prepared by syringe homogenization. (A) At 30 dpi animals were grouped based on EAE course: mild, severe or progression. Data are representative of six independent experiments. Individual time points represent mean Â± s.e.m. <italic toggle="yes">P</italic> values were determined by two-way ANOVA with Sidakâs multiple comparisons test. (B) Representative images showing demyelination and infiltration in the lumbar spinal cord of healthy control, at EAE peak, and in chronic mild, severe and progressive EAE. (C) CD4<sup>+</sup> T cells and Iba1<sup>+</sup> macrophages/microglia in the lumbar spinal cord of healthy control, at EAE peak, and in chronic mild, severe and progressive EAE. Scale bar 100 Âµm for Luxol-Nissl and 50 Âµm for CD4/Iba1. dpi, days post immunization.</p></caption><graphic xlink:href="396036v4_fig3" position="float" orientation="portrait" hwp:id="graphic-4"/></fig><table-wrap id="tbl2" orientation="portrait" position="float" hwp:id="T2" hwp:rev-id="xref-table-wrap-2-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;396036v4/TBL2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T2</object-id><object-id pub-id-type="publisher-id">tbl2</object-id><label>Table 2.</label><caption hwp:id="caption-5"><title hwp:id="title-24">Clinical assessment of EAE in C57BL/6 <italic toggle="yes">WT</italic> mice</title></caption><graphic xlink:href="396036v4_tbl2" position="float" orientation="portrait" hwp:id="graphic-5"/></table-wrap><fig id="fig4" position="float" fig-type="figure" orientation="portrait" hwp:id="F4" hwp:rev-id="xref-fig-4-1 xref-fig-4-2 xref-fig-4-3 xref-fig-4-4"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;396036v4/FIG4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F4</object-id><object-id pub-id-type="publisher-id">fig4</object-id><label>Fig. 4.</label><caption hwp:id="caption-6"><title hwp:id="title-25">Reduction in CD11c<sup>+</sup> microglia at EAE progression in <italic toggle="yes">WT</italic> mice.</title><p hwp:id="p-28">EAE was induced in C57BL/6 <italic toggle="yes">WT</italic> mice with MOG prepared by syringe homogenization. Flow cytometry analysis of cells isolated from the brain and spinal cord of healthy mice, at EAE peak, EAE progression and at 30 days of mild and severe EAE. (A-D) Flow cytometry analysis of CD45<sup>+</sup> cells, Ly6G<sup>+</sup> neutrophils, CD11b<sup>+</sup>CD45<sup>hi</sup>Ly6G<sup>-</sup> macrophages/monocytes and CD11b<sup>+</sup>CD45<sup>lo</sup> microglia, CD11c<sup>+</sup> cells. (E) Gating strategy to differentiate cDC, moDC and CD11c<sup>+</sup> microglia by expression of CD45 and CD11b. (F-M) Quantification of CD45<sup>+</sup> cells, Ly6G<sup>+</sup> neutrophils, CD11b<sup>+</sup>CD45<sup>hi</sup> macrophages/monocytes, CD11c<sup>+</sup> cells, cDC, moDC, CD11b<sup>+</sup>CD45<sup>lo</sup> microglia, and CD11c<sup>+</sup> microglia. Data are representative of six independent experiments. Each point represents an individual animal. <italic toggle="yes">P</italic> values were determined by One-way ANOVA with Tukeyâs post hoc test. dpi, days post immunization.</p></caption><graphic xlink:href="396036v4_fig4" position="float" orientation="portrait" hwp:id="graphic-6"/></fig></sec><sec id="s3d" hwp:id="sec-16"><title hwp:id="title-26">CD11c<sup>+</sup> microglia contact astrocyte processes and glia limitans</title><p hwp:id="p-29">Astrocytes orchestrate immune cell parenchymal infiltration (<xref rid="c26" ref-type="bibr" hwp:id="xref-ref-26-1" hwp:rel-id="ref-26">Horng et al., 2017</xref>; <xref rid="c31" ref-type="bibr" hwp:id="xref-ref-31-1" hwp:rel-id="ref-31">Kim et al., 2014</xref>). We examined localization of CD11c<sup>+</sup> microglia in relation to astrocytes. Commercially available antibodies were not able to detect CD11c<sup>+</sup> cells by immunohistochemistry, likely due to low expression of CD11c in migrating and activated CD11c<sup>+</sup> cells (<xref rid="c38" ref-type="bibr" hwp:id="xref-ref-38-2" hwp:rel-id="ref-38">Merad et al., 2013</xref>; <xref rid="c43" ref-type="bibr" hwp:id="xref-ref-43-1" hwp:rel-id="ref-43">Prodinger et al., 2011</xref>). To visualize CD11c<sup>+</sup> cells, we used expression of eGFP under the CD11c promoter. In protected <italic toggle="yes">KO</italic> males, we found dendritic-like CD11c<sup>+</sup> microglia in the vicinity to astrocytes and blood vessels (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-1" hwp:rel-id="F5">Fig. 5A-B</xref>). CD11c<sup>+</sup> microglia were abundant in <italic toggle="yes">WT</italic> mice with chronic mild EAE (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-2" hwp:rel-id="F5">Fig. 5C</xref>). Dendritic-like CD11c<sup>+</sup> microglia with stellate thick processes formed contacts with astrocytes (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-3" hwp:rel-id="F5">Fig. 5D</xref>). In progressed <italic toggle="yes">KO</italic> females, disorganized processes of hypertrophic astrocytes were surrounded by infiltrating moDC / ameboid CD11c<sup>+</sup> microglia (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-4" hwp:rel-id="F5">Fig. 5E-F</xref>). Dendritic-like CD11c<sup>+</sup> microglia could not be differentiated from infiltrating moDC by morphology. Infiltration of immune cells into the CNS parenchyma is dependent on astrocyte-derived CCL2 (<xref rid="c17" ref-type="bibr" hwp:id="xref-ref-17-1" hwp:rel-id="ref-17">Dogan et al., 2008</xref>; <xref rid="c31" ref-type="bibr" hwp:id="xref-ref-31-2" hwp:rel-id="ref-31">Kim et al., 2014</xref>; <xref rid="c40" ref-type="bibr" hwp:id="xref-ref-40-1" hwp:rel-id="ref-40">Moreno et al., 2014</xref>). We found upregulation of CCL2 expression in hypertrophic reactive astrocytes in progressed <italic toggle="yes">KO</italic> females (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-5" hwp:rel-id="F5">Fig. 5G-H</xref>). Our data suggest that CD11c<sup>+</sup> microglia interaction with astrocytes at the glia limitans is dysregulated in EAE progression.</p><fig id="fig5" position="float" fig-type="figure" orientation="portrait" hwp:id="F5" hwp:rev-id="xref-fig-5-1 xref-fig-5-2 xref-fig-5-3 xref-fig-5-4 xref-fig-5-5"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;396036v4/FIG5</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F5</object-id><object-id pub-id-type="publisher-id">fig5</object-id><label>Fig. 5.</label><caption hwp:id="caption-7"><title hwp:id="title-27">CD11c<sup>+</sup> microglia form contacts with astrocytes at the glia limitans.</title><p hwp:id="p-30">CD11c<sup>+</sup> cells were visualized using CD11c promoter-driven expression of eGFP. (A-B) In the spinal cord white matter of protected <italic toggle="yes">KO</italic> males, parenchymal and perivascular astrocytes were surrounded by CD11c-eGFP<sup>+</sup> microglia (arrows). moDC (arrowheads) were trapped within perivascular spaces. (C) CD11c<sup>+</sup> microglia in contact with parenchymal astrocyte processes and glia limitans covering Lectin<sup>+</sup> blood vessel (arrows) in <italic toggle="yes">WT Itgax</italic>-cre-EGFP mice in chronic mild EAE. (D) Orthogonal projection shows that dendritic-like CD11c<sup>+</sup> microglia form contacts with astrocyte processes. (E) CD11c-eGFP<sup>+</sup> moDC/reactive microglia surround hypertrophic processes of reactive astrocytes in the ventral spinal cord of progressed <italic toggle="yes">KO</italic> female mice (arrows). (F) moDC in the perivascular space (arrowheads) and parenchyma (arrows). (G) Increased CCL2 expression in reactive astrocytes in progressed <italic toggle="yes">KO</italic> females. Scale bars 10 Âµm for A-B, D-G and 5 Âµm for C. (G) mRNA transcription levels of CCL2 in the lumbar spinal cords of <italic toggle="yes">KO</italic> male and progressed <italic toggle="yes">KO</italic> female mice. Data are representative of three independent experiments. Each point represents one individual animal. P values were determined by Studentâs t-test. F, females; <italic toggle="yes">KO</italic>, knockout; M, males; Prog, progression.</p></caption><graphic xlink:href="396036v4_fig5" position="float" orientation="portrait" hwp:id="graphic-7"/></fig></sec></sec><sec id="s4" hwp:id="sec-17"><title hwp:id="title-28">Discussion</title><p hwp:id="p-31">EAE allows to study a variety of clinical features of MS (<xref rid="c14" ref-type="bibr" hwp:id="xref-ref-14-1" hwp:rel-id="ref-14">Constantinescu et al., 2011</xref>). Here we demonstrate that mice that develop mild EAE after MOG immunization are primed to undergo spontaneous EAE progression around 30 dpi. EAE progression appeared in 58% of female mice lacking <italic toggle="yes">p38Î±</italic> in CD11c<sup>+</sup> cells and â¼40% of <italic toggle="yes">WT</italic> mice both of which initially developed mild EAE. Similar progression of clinical symptoms around 30 dpi was reported in non-obese diabetic mice used as a model of EAE progression (<xref rid="c7" ref-type="bibr" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7">Baker et al., 2019</xref>; <xref rid="c9" ref-type="bibr" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">Basso et al., 2008</xref>; <xref rid="c10" ref-type="bibr" hwp:id="xref-ref-10-1" hwp:rel-id="ref-10">Buonvicino et al., 2019</xref>; <xref rid="c18" ref-type="bibr" hwp:id="xref-ref-18-1" hwp:rel-id="ref-18">Encinas et al., 1999</xref>; <xref rid="c48" ref-type="bibr" hwp:id="xref-ref-48-1" hwp:rel-id="ref-48">Tanabe et al., 2019</xref>). Why EAE progression follows a 30 dpi pattern and what triggers progression in a fraction of animals with mild EAE remains to be investigated.</p><p hwp:id="p-32">Secondary antigenic epitope spreading has been identified as a molecular trigger in MS relapse and progression involving Th1 and Th17 cells (<xref rid="c5" ref-type="bibr" hwp:id="xref-ref-5-1" hwp:rel-id="ref-5">Babaloo et al., 2015</xref>; <xref rid="c8" ref-type="bibr" hwp:id="xref-ref-8-2" hwp:rel-id="ref-8">Balashov et al., 1997</xref>; <xref rid="c37" ref-type="bibr" hwp:id="xref-ref-37-1" hwp:rel-id="ref-37">McRae et al., 1995</xref>; <xref rid="c44" ref-type="bibr" hwp:id="xref-ref-44-1" hwp:rel-id="ref-44">Romme Christensen et al., 2013</xref>). Activation of epitope-specific Th cells is dependent on antigen-presenting CD11c<sup>+</sup> cells (<xref rid="c12" ref-type="bibr" hwp:id="xref-ref-12-1" hwp:rel-id="ref-12">Chastain et al., 2011</xref>; <xref rid="c21" ref-type="bibr" hwp:id="xref-ref-21-3" hwp:rel-id="ref-21">Giles et al., 2018</xref>; <xref rid="c24" ref-type="bibr" hwp:id="xref-ref-24-2" hwp:rel-id="ref-24">Greter et al., 2005</xref>; <xref rid="c41" ref-type="bibr" hwp:id="xref-ref-41-2" hwp:rel-id="ref-41">Mundt et al., 2019</xref>) and requires p38Î± for induction of the Th17 population (<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-3" hwp:rel-id="ref-16">Di Mitri et al., 2015</xref>; <xref rid="c27" ref-type="bibr" hwp:id="xref-ref-27-5" hwp:rel-id="ref-27">Huang et al., 2012</xref>). We found that both, Th1 and Th17 cells were involved in chronic EAE progression in <italic toggle="yes">WT</italic> mice. However, re-activation of Th1 cells through p38Î±-independent mechanism was enough to trigger EAE progression in <italic toggle="yes">KO</italic> female mice, suggesting mechanistic differences in immune response between initial EAE peak and progression of chronic EAE. <italic toggle="yes">KO</italic> males were protected from EAE progression. Whether Th17 cells are required for EAE progression in males remains to be examined.</p><p hwp:id="p-33">Comparing compositions of immune cells and patterns of parenchymal infiltration between EAE phenotypes, we found selective reduction in CD11c<sup>+</sup> microglia and dispersed coalescent parenchymal infiltration as characteristic features of chronic EAE progression. Importantly, dispersed infiltration but with lesser cell density was also evident in chronic severe EAE, suggesting that dispersed, in contrast to focal infiltration is a pathological hallmark of irreversible disability.</p><p hwp:id="p-34">Signaling via p38 MAPK is involved in hormone-dependent sexual dimorphism of the immune response with variable outcomes depending on cell type and condition. In microglia, p38 MAPK was identified as a cause of neuropathic and inflammatory pain in males in chronic constriction injury and mechanical allodynia (<xref rid="c47" ref-type="bibr" hwp:id="xref-ref-47-1" hwp:rel-id="ref-47">Sorge et al., 2015</xref>; <xref rid="c49" ref-type="bibr" hwp:id="xref-ref-49-1" hwp:rel-id="ref-49">Taves et al., 2016</xref>). Testosterone-dependent increase in p38 MAPK phosphorylation in splenic and peritoneal macrophages was reported in male mice after trauma-hemorrhage (<xref rid="c4" ref-type="bibr" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">Angele et al., 2003</xref>). We found that p38Î± was involved in maintaining CD11c<sup>+</sup> microglia in female mice and reduction in CD11c<sup>+</sup> microglia correlated with increased rate of EAE progression in <italic toggle="yes">KO</italic> females. In contrast, protection from EAE progression in <italic toggle="yes">KO</italic> males was associated with the presence of CD11c<sup>+</sup> microglia in close contact with astrocytes and at the glia limitans. A biased role of p38Î± in driving CD11c<sup>+</sup> microglia reduction in males would explain the lack of EAE progression in <italic toggle="yes">KO</italic> male mice. Defining the molecular mechanism of CD11c<sup>+</sup> microglia reduction is needed to further understand the sex-specific role of p38Î± at EAE progression.</p><p hwp:id="p-35">In our study, <italic toggle="yes">KO</italic> female mice showed a delay in EAE onset and peak, indicating a delay in the peripheral immune response involving cDC and/or moDC. This is supported by an earlier study where female mice lacking p38Î± in myeloid cells showed improvement of EAE clinical symptoms while their male cohorts developed exacerbated EAE (<xref rid="c32" ref-type="bibr" hwp:id="xref-ref-32-4" hwp:rel-id="ref-32">Krementsov et al., 2014</xref>). Reduced peripheral immune response may explain the lack of EAE progression in the fraction of <italic toggle="yes">KO</italic> females with minor spinal cord infiltration. Changes in the peripheral immune response within <italic toggle="yes">KO</italic> females may be caused by unequal efficiency of <italic toggle="yes">p38Î±</italic> deletion or compensatory activity of alternative p38 MAPK subunits, such as p38Î² and p38d (<xref rid="c27" ref-type="bibr" hwp:id="xref-ref-27-6" hwp:rel-id="ref-27">Huang et al., 2012</xref>). Taking together, variable effects of p38Î± function may explain why many of p38 MAPK inhibitors failed to fulfill their expectations in clinical trials to date and emphasize the need of cell-specific therapeutic approaches (<xref rid="c23" ref-type="bibr" hwp:id="xref-ref-23-1" hwp:rel-id="ref-23">Goldstein et al., 2010</xref>; <xref rid="c32" ref-type="bibr" hwp:id="xref-ref-32-5" hwp:rel-id="ref-32">Krementsov et al., 2013</xref>).</p><p hwp:id="p-36">Dendritic-like CD11c<sup>+</sup> microglia localized at the glia limitans are found in the brain, spinal cord and optic nerve under healthy conditions and are suggested to play a role in astrocyte glia limitans organization (<xref rid="c43" ref-type="bibr" hwp:id="xref-ref-43-2" hwp:rel-id="ref-43">Prodinger et al., 2011</xref>). Glia limitans astrocytic endfeet surround blood-brain barrier endothelial cells and form a physical border between perivascular spaces and CNS parenchyma (<xref rid="c26" ref-type="bibr" hwp:id="xref-ref-26-2" hwp:rel-id="ref-26">Horng et al., 2017</xref>). Dendritic-like CD11c<sup>+</sup> microglia were abundant in the spinal cord of mice with chronic mild EAE, where immune cells were restricted from entering parenchyma. These CD11c<sup>+</sup> microglia formed physical contacts with astrocyte processes suggesting their direct interaction with astrocytes to limit immune cell parenchymal entry. Expression of triggering receptor expressed on myeloid cells (TREM2) has been associated with CD11c<sup>+</sup> microglia in EAE and an animal model of Alzheimerâs disease (<xref rid="c30" ref-type="bibr" hwp:id="xref-ref-30-2" hwp:rel-id="ref-30">Keren-Shaul et al., 2017</xref>; <xref rid="c42" ref-type="bibr" hwp:id="xref-ref-42-1" hwp:rel-id="ref-42">Piccio et al., 2007</xref>). Supporting the concept of a potential protective role of CD11c<sup>+</sup> microglia in CNS infiltration, diffuse parenchymal infiltration and increase of clinical disability in EAE was found after blockade of TREM2 activity with specific antibody (<xref rid="c42" ref-type="bibr" hwp:id="xref-ref-42-2" hwp:rel-id="ref-42">Piccio et al., 2007</xref>).</p></sec><sec id="s5" hwp:id="sec-18"><title hwp:id="title-29">Conclusion</title><p hwp:id="p-37">Our study provides novel insight into the cellular mechanisms underlying clinical progression during chronic EAE. We identified reduction in CD11c<sup>+</sup> microglia and the specific pattern of dispersed parenchymal infiltration as pathological hallmarks of EAE progression. Our data suggest a protective role of dendritic-like CD11c<sup>+</sup> microglia in controlling CNS infiltration and EAE progression through interaction with astrocytes.</p></sec><sec sec-type="supplementary-material" hwp:id="sec-19"><title hwp:id="title-30">Supporting information</title><supplementary-material position="float" orientation="portrait" hwp:id="DC1"><object-id pub-id-type="other" hwp:sub-type="slug">DC1</object-id><label>Supplementary Figures 1-4</label><media xlink:href="supplements/396036_file04.pdf" position="float" orientation="portrait" hwp:id="media-1"/></supplementary-material></sec></body><back><ack hwp:id="ack-1"><title hwp:id="title-31">Acknowledgements</title><p hwp:id="p-38">This work was in parts supported by grants from National Institutes of Health (R01HD087566 to W.D.) and Shriners Hospital for Children (87310-NCA-19 to O.C.).</p></ack><sec id="s6" hwp:id="sec-20"><title hwp:id="title-32">Author contributions</title><p hwp:id="p-39">O.V.C. and F.M. designed the research, performed experiments, interpreted the data, wrote and edited the manuscript. Z.D., A.Z., D.J.D., and A.M.H. performed experiments. P.B., D.P., A.S., and W.D. interpreted the data and edited the manuscript.</p></sec><sec id="s7" hwp:id="sec-21"><title hwp:id="title-33">Conflict of interest</title><p hwp:id="p-40">The authors have declared that no conflict of interest exists.</p></sec><ref-list hwp:id="ref-list-1"><title hwp:id="title-34">References</title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Adelmann M."><surname>Adelmann</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal>, <year>1995</year>. <article-title hwp:id="article-title-2">The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat</article-title>. <source hwp:id="source-1">J Neuroimmunol</source>. <volume>63</volume>, <fpage>17</fpage>â<lpage>27</lpage>.</citation></ref><ref id="c2" hwp:id="ref-2" hwp:rev-id="xref-ref-2-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.2" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="Ajami B."><surname>Ajami</surname>, <given-names>B.</given-names></string-name>, <etal>et al.</etal>, <year>2011</year>. <article-title hwp:id="article-title-3">Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool</article-title>. <source hwp:id="source-2">Nat Neurosci</source>. <volume>14</volume>, <fpage>1142</fpage>â<lpage>9</lpage>.</citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Anderson P. J."><surname>Anderson</surname>, <given-names>P. J.</given-names></string-name>, <etal>et al.</etal>, <year>2011</year>. <article-title hwp:id="article-title-4">Attention problems in a representative sample of extremely preterm/extremely low birth weight children</article-title>. <source hwp:id="source-3">Dev Neuropsychol</source>. <volume>36</volume>, <fpage>57</fpage>â<lpage>73</lpage>.</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Angele M. K."><surname>Angele</surname>, <given-names>M. K.</given-names></string-name>, <etal>et al.</etal>, <year>2003</year>. <article-title hwp:id="article-title-5">Sex-specific p38 MAP kinase activation following trauma-hemorrhage: involvement of testosterone and estradiol</article-title>. <source hwp:id="source-4">Am J Physiol Endocrinol Metab</source>. <volume>285</volume>, <fpage>E189</fpage>â<lpage>96</lpage>.</citation></ref><ref id="c5" hwp:id="ref-5" hwp:rev-id="xref-ref-5-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Babaloo Z."><surname>Babaloo</surname>, <given-names>Z.</given-names></string-name>, <etal>et al.</etal>, <year>2015</year>. <article-title hwp:id="article-title-6">The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels</article-title>. <source hwp:id="source-5">Immunol Lett</source>. <volume>164</volume>, <fpage>76</fpage>â<lpage>80</lpage>.</citation></ref><ref id="c6" hwp:id="ref-6" hwp:rev-id="xref-ref-6-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Baecher-Allan C."><surname>Baecher-Allan</surname>, <given-names>C.</given-names></string-name>, <etal>et al.</etal>, <year>2018</year>. <article-title hwp:id="article-title-7">Multiple Sclerosis: Mechanisms and Immunotherapy</article-title>. <source hwp:id="source-6">Neuron</source>. <volume>97</volume>, <fpage>742</fpage>â<lpage>768</lpage>.</citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Baker D."><surname>Baker</surname>, <given-names>D.</given-names></string-name>, <etal>et al.</etal>, <year>2019</year>. <article-title hwp:id="article-title-8">Autoimmune encephalomyelitis in NOD mice is not initially a progressive multiple sclerosis model</article-title>. <source hwp:id="source-7">Ann Clin Transl Neurol</source>. <volume>6</volume>, <fpage>1362</fpage>â<lpage>1372</lpage>.</citation></ref><ref id="c8" hwp:id="ref-8" hwp:rev-id="xref-ref-8-1 xref-ref-8-2"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.8" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Balashov K. E."><surname>Balashov</surname>, <given-names>K. E.</given-names></string-name>, <etal>et al.</etal>, <year>1997</year>. <article-title hwp:id="article-title-9">Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand</article-title>. <source hwp:id="source-8">Proc Natl Acad Sci U S A</source>. <volume>94</volume>, <fpage>599</fpage>â<lpage>603</lpage>.</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Basso A. S."><surname>Basso</surname>, <given-names>A. S.</given-names></string-name>, <etal>et al.</etal>, <year>2008</year>. <article-title hwp:id="article-title-10">Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis</article-title>. <source hwp:id="source-9">J Clin Invest</source>. <volume>118</volume>, <fpage>1532</fpage>â<lpage>43</lpage>.</citation></ref><ref id="c10" hwp:id="ref-10" hwp:rev-id="xref-ref-10-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.10" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Buonvicino D."><surname>Buonvicino</surname>, <given-names>D.</given-names></string-name>, <etal>et al.</etal>, <year>2019</year>. <article-title hwp:id="article-title-11">Neuroimmunological characterization of a mouse model of primary progressive experimental autoimmune encephalomyelitis and effects of immunosuppressive or neuroprotective strategies on disease evolution</article-title>. <source hwp:id="source-10">Exp Neurol</source>. <volume>322</volume>, <fpage>113065</fpage>.</citation></ref><ref id="c11" hwp:id="ref-11" hwp:rev-id="xref-ref-11-1 xref-ref-11-2"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.11" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Butovsky O."><surname>Butovsky</surname>, <given-names>O.</given-names></string-name>, <etal>et al.</etal>, <year>2006</year>. <article-title hwp:id="article-title-12">Glatiramer acetate fights against Alzheimerâs disease by inducing dendritic-like microglia expressing insulin-like growth factor 1</article-title>. <source hwp:id="source-11">Proc Natl Acad Sci U S A</source>. <volume>103</volume>, <fpage>11784</fpage>â<lpage>9</lpage>.</citation></ref><ref id="c12" hwp:id="ref-12" hwp:rev-id="xref-ref-12-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Chastain E. M."><surname>Chastain</surname>, <given-names>E. M.</given-names></string-name>, <etal>et al.</etal>, <year>2011</year>. <article-title hwp:id="article-title-13">The role of antigen presenting cells in multiple sclerosis</article-title>. <source hwp:id="source-12">Biochim Biophys Acta</source>. <volume>1812</volume>, <fpage>265</fpage>â<lpage>74</lpage>.</citation></ref><ref id="c13" hwp:id="ref-13" hwp:rev-id="xref-ref-13-1 xref-ref-13-2 xref-ref-13-3 xref-ref-13-4"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Chechneva O. V."><surname>Chechneva</surname>, <given-names>O. V.</given-names></string-name>, <etal>et al.</etal>, <year>2011</year>. <article-title hwp:id="article-title-14">Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord</article-title>. <source hwp:id="source-13">Neurobiol Dis</source>. <volume>44</volume>, <fpage>63</fpage>â<lpage>72</lpage>.</citation></ref><ref id="c14" hwp:id="ref-14" hwp:rev-id="xref-ref-14-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Constantinescu C. S."><surname>Constantinescu</surname>, <given-names>C. S.</given-names></string-name>, <etal>et al.</etal>, <year>2011</year>. <article-title hwp:id="article-title-15">Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)</article-title>. <source hwp:id="source-14">Br J Pharmacol</source>. <volume>164</volume>, <fpage>1079</fpage>â<lpage>106</lpage>.</citation></ref><ref id="c15" hwp:id="ref-15" hwp:rev-id="xref-ref-15-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Coret F."><surname>Coret</surname>, <given-names>F.</given-names></string-name>, <etal>et al.</etal>, <year>2018</year>. <article-title hwp:id="article-title-16">Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies</article-title>. <source hwp:id="source-15">Mult Scler J Exp Transl Clin</source>. <volume>4</volume>, <fpage>2055217318783347</fpage>.</citation></ref><ref id="c16" hwp:id="ref-16" hwp:rev-id="xref-ref-16-1 xref-ref-16-2 xref-ref-16-3"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Di Mitri D."><surname>Di Mitri</surname>, <given-names>D.</given-names></string-name>, <etal>et al.</etal>, <year>2015</year>. <article-title hwp:id="article-title-17">The p38 mitogen-activated protein kinase cascade modulates T helper type 17 differentiation and functionality in multiple sclerosis</article-title>. <source hwp:id="source-16">Immunology</source>. <volume>146</volume>, <fpage>251</fpage>â<lpage>63</lpage>.</citation></ref><ref id="c17" hwp:id="ref-17" hwp:rev-id="xref-ref-17-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Dogan R. N."><surname>Dogan</surname>, <given-names>R. N.</given-names></string-name>, <etal>et al.</etal>, <year>2008</year>. <article-title hwp:id="article-title-18">Production of CCL2 by central nervous system cells regulates development of murine experimental autoimmune encephalomyelitis through the recruitment of TNF-and iNOS-expressing macrophages and myeloid dendritic cells</article-title>. <source hwp:id="source-17">J Immunol</source>. <volume>180</volume>, <fpage>7376</fpage>â<lpage>84</lpage>.</citation></ref><ref id="c18" hwp:id="ref-18" hwp:rev-id="xref-ref-18-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Encinas J. A."><surname>Encinas</surname>, <given-names>J. A.</given-names></string-name>, <etal>et al.</etal>, <year>1999</year>. <article-title hwp:id="article-title-19">QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing Il2</article-title>. <source hwp:id="source-18">Nat Genet</source>. <volume>21</volume>, <fpage>158</fpage>â<lpage>60</lpage>.</citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Fischer H. G."><surname>Fischer</surname>, <given-names>H. G.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Reichmann G."><surname>Reichmann</surname>, <given-names>G.</given-names></string-name>, <year>2001</year>. <article-title hwp:id="article-title-20">Brain dendritic cells and macrophages/microglia in central nervous system inflammation</article-title>. <source hwp:id="source-19">J Immunol</source>. <volume>166</volume>, <fpage>2717</fpage>â<lpage>26</lpage>.</citation></ref><ref id="c20" hwp:id="ref-20" hwp:rev-id="xref-ref-20-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Ford A. L."><surname>Ford</surname>, <given-names>A. L.</given-names></string-name>, <etal>et al.</etal>, <year>1995</year>. <article-title hwp:id="article-title-21">Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared</article-title>. <source hwp:id="source-20">J Immunol</source>. <volume>154</volume>, <fpage>4309</fpage>â<lpage>21</lpage>.</citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1 xref-ref-21-2 xref-ref-21-3"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.21" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Giles D. A."><surname>Giles</surname>, <given-names>D. A.</given-names></string-name>, <etal>et al.</etal>, <year>2018</year>. <article-title hwp:id="article-title-22">CNS-resident classical DCs play a critical role in CNS autoimmune disease</article-title>. <source hwp:id="source-21">J Clin Invest</source>. <volume>128</volume>, <fpage>5322</fpage>â<lpage>5334</lpage>.</citation></ref><ref id="c22" hwp:id="ref-22" hwp:rev-id="xref-ref-22-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="Goldschmidt C."><surname>Goldschmidt</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western" hwp:sortable="McGinley M. P."><surname>McGinley</surname>, <given-names>M. P.</given-names></string-name>, <year>2021</year>. <article-title hwp:id="article-title-23">Advances in the Treatment of Multiple Sclerosis</article-title>. <source hwp:id="source-22">Neurol Clin</source>. <volume>39</volume>, <fpage>21</fpage>â<lpage>33</lpage>.</citation></ref><ref id="c23" hwp:id="ref-23" hwp:rev-id="xref-ref-23-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="Goldstein D. M."><surname>Goldstein</surname>, <given-names>D. M.</given-names></string-name>, <etal>et al.</etal>, <year>2010</year>. <article-title hwp:id="article-title-24">Selective p38alpha inhibitors clinically evaluated for the treatment of chronic inflammatory disorders</article-title>. <source hwp:id="source-23">J Med Chem</source>. <volume>53</volume>, <fpage>2345</fpage>â<lpage>53</lpage>.</citation></ref><ref id="c24" hwp:id="ref-24" hwp:rev-id="xref-ref-24-1 xref-ref-24-2"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Greter M."><surname>Greter</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal>, <year>2005</year>. <article-title hwp:id="article-title-25">Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis</article-title>. <source hwp:id="source-24">Nat Med</source>. <volume>11</volume>, <fpage>328</fpage>â<lpage>34</lpage>.</citation></ref><ref id="c25" hwp:id="ref-25" hwp:rev-id="xref-ref-25-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Hagemeyer N."><surname>Hagemeyer</surname>, <given-names>N.</given-names></string-name>, <etal>et al.</etal>, <year>2017</year>. <article-title hwp:id="article-title-26">Microglia contribute to normal myelinogenesis and to oligodendrocyte progenitor maintenance during adulthood</article-title>. <source hwp:id="source-25">Acta Neuropathol</source>. <volume>134</volume>, <fpage>441</fpage>â<lpage>458</lpage>.</citation></ref><ref id="c26" hwp:id="ref-26" hwp:rev-id="xref-ref-26-1 xref-ref-26-2"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.26" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-26"><string-name name-style="western" hwp:sortable="Horng S."><surname>Horng</surname>, <given-names>S.</given-names></string-name>, <etal>et al.</etal>, <year>2017</year>. <article-title hwp:id="article-title-27">Astrocytic tight junctions control inflammatory CNS lesion pathogenesis</article-title>. <source hwp:id="source-26">J Clin Invest</source>. <volume>127</volume>, <fpage>3136</fpage>â<lpage>3151</lpage>.</citation></ref><ref id="c27" hwp:id="ref-27" hwp:rev-id="xref-ref-27-1 xref-ref-27-2 xref-ref-27-3 xref-ref-27-4 xref-ref-27-5 xref-ref-27-6"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.27" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-27"><string-name name-style="western" hwp:sortable="Huang G."><surname>Huang</surname>, <given-names>G.</given-names></string-name>, <etal>et al.</etal>, <year>2012</year>. <article-title hwp:id="article-title-28">Signaling via the kinase p38alpha programs dendritic cells to drive TH17 differentiation and autoimmune inflammation</article-title>. <source hwp:id="source-27">Nat Immunol</source>. <volume>13</volume>, <fpage>152</fpage>â<lpage>61</lpage>.</citation></ref><ref id="c28" hwp:id="ref-28" hwp:rev-id="xref-ref-28-1"><citation publication-type="other" citation-type="journal" ref:id="396036v4.28" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-28"><string-name name-style="western" hwp:sortable="Jordao M. J. C."><surname>Jordao</surname>, <given-names>M. J. C.</given-names></string-name>, <etal>et al.</etal>, <year>2019</year>. <article-title hwp:id="article-title-29">Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation</article-title>. <source hwp:id="source-28">Science</source>. <volume>363</volume>.</citation></ref><ref id="c29" hwp:id="ref-29" hwp:rev-id="xref-ref-29-1 xref-ref-29-2"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.29" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-29"><string-name name-style="western" hwp:sortable="Kamphuis W."><surname>Kamphuis</surname>, <given-names>W.</given-names></string-name>, <etal>et al.</etal>, <year>2016</year>. <article-title hwp:id="article-title-30">Transcriptional profiling of CD11c-positive microglia accumulating around amyloid plaques in a mouse model for Alzheimerâs disease</article-title>. <source hwp:id="source-29">Biochim Biophys Acta</source>. <volume>1862</volume>, <fpage>1847</fpage>â<lpage>60</lpage>.</citation></ref><ref id="c30" hwp:id="ref-30" hwp:rev-id="xref-ref-30-1 xref-ref-30-2"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.30" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-30"><string-name name-style="western" hwp:sortable="Keren-Shaul H."><surname>Keren-Shaul</surname>, <given-names>H.</given-names></string-name>, <etal>et al.</etal>, <year>2017</year>. <article-title hwp:id="article-title-31">A Unique Microglia Type Associated with Restricting Development of Alzheimerâs Disease</article-title>. <source hwp:id="source-30">Cell</source>. <volume>169</volume>, <fpage>1276</fpage>â<lpage>1290</lpage> e17.</citation></ref><ref id="c31" hwp:id="ref-31" hwp:rev-id="xref-ref-31-1 xref-ref-31-2"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.31" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-31"><string-name name-style="western" hwp:sortable="Kim R. Y."><surname>Kim</surname>, <given-names>R. Y.</given-names></string-name>, <etal>et al.</etal>, <year>2014</year>. <article-title hwp:id="article-title-32">Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis</article-title>. <source hwp:id="source-31">J Neuroimmunol</source>. <volume>274</volume>, <fpage>53</fpage>â<lpage>61</lpage>.</citation></ref><ref id="c32" hwp:id="ref-32" hwp:rev-id="xref-ref-32-1 xref-ref-32-2 xref-ref-32-3 xref-ref-32-4 xref-ref-32-5"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.32" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-32"><string-name name-style="western" hwp:sortable="Krementsov D. N."><surname>Krementsov</surname>, <given-names>D. N.</given-names></string-name>, <etal>et al.</etal>, <year>2014</year>. <article-title hwp:id="article-title-33">Sex-specific control of central nervous system autoimmunity by p38 mitogen-activated protein kinase signaling in myeloid cells</article-title>. <source hwp:id="source-32">Ann Neurol</source>. <volume>75</volume>, <fpage>50</fpage>â<lpage>66</lpage>.</citation></ref><ref id="c33" hwp:id="ref-33"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.33" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-33"><string-name name-style="western" hwp:sortable="Krementsov D. N."><surname>Krementsov</surname>, <given-names>D. N.</given-names></string-name>, <etal>et al.</etal>, <year>2013</year>. <article-title hwp:id="article-title-34">The emerging role of p38 mitogen-activated protein kinase in multiple sclerosis and its models</article-title>. <source hwp:id="source-33">Mol Cell Biol</source>. <volume>33</volume>, <fpage>3728</fpage>â<lpage>34</lpage>.</citation></ref><ref id="c34" hwp:id="ref-34" hwp:rev-id="xref-ref-34-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.34" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-34"><string-name name-style="western" hwp:sortable="Livak K. J."><surname>Livak</surname>, <given-names>K. J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schmittgen T. D."><surname>Schmittgen</surname>, <given-names>T. D.</given-names></string-name>, <year>2001</year>. <article-title hwp:id="article-title-35">Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method</article-title>. <source hwp:id="source-34">Methods</source>. <volume>25</volume>, <fpage>402</fpage>â<lpage>8</lpage>.</citation></ref><ref id="c35" hwp:id="ref-35" hwp:rev-id="xref-ref-35-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.35" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-35"><string-name name-style="western" hwp:sortable="Lo U."><surname>Lo</surname>, <given-names>U.</given-names></string-name>, <etal>et al.</etal>, <year>2014</year>. <article-title hwp:id="article-title-36">p38alpha (MAPK14) critically regulates the immunological response and the production of specific cytokines and chemokines in astrocytes</article-title>. <source hwp:id="source-35">Sci Rep</source>. <volume>4</volume>, <fpage>7405</fpage>.</citation></ref><ref id="c36" hwp:id="ref-36" hwp:rev-id="xref-ref-36-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.36" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-36"><string-name name-style="western" hwp:sortable="Lock C."><surname>Lock</surname>, <given-names>C.</given-names></string-name>, <etal>et al.</etal>, <year>2002</year>. <article-title hwp:id="article-title-37">Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis</article-title>. <source hwp:id="source-36">Nat Med</source>. <volume>8</volume>, <fpage>500</fpage>â<lpage>8</lpage>.</citation></ref><ref id="c37" hwp:id="ref-37" hwp:rev-id="xref-ref-37-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.37" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-37"><string-name name-style="western" hwp:sortable="McRae B. L."><surname>McRae</surname>, <given-names>B. L.</given-names></string-name>, <etal>et al.</etal>, <year>1995</year>. <article-title hwp:id="article-title-38">Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis</article-title>. <source hwp:id="source-37">J Exp Med</source>. <volume>182</volume>, <fpage>75</fpage>â<lpage>85</lpage>.</citation></ref><ref id="c38" hwp:id="ref-38" hwp:rev-id="xref-ref-38-1 xref-ref-38-2"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.38" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-38"><string-name name-style="western" hwp:sortable="Merad M."><surname>Merad</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal>, <year>2013</year>. <article-title hwp:id="article-title-39">The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting</article-title>. <source hwp:id="source-38">Annu Rev Immunol</source>. <volume>31</volume>, <fpage>563</fpage>â<lpage>604</lpage>.</citation></ref><ref id="c39" hwp:id="ref-39" hwp:rev-id="xref-ref-39-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.39" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-39"><string-name name-style="western" hwp:sortable="Miller S. D."><surname>Miller</surname>, <given-names>S. D.</given-names></string-name>, <etal>et al.</etal>, <year>2007</year>. <article-title hwp:id="article-title-40">Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis</article-title>. <source hwp:id="source-39">Ann N Y Acad Sci</source>. <volume>1103</volume>, <fpage>179</fpage>â<lpage>91</lpage>.</citation></ref><ref id="c40" hwp:id="ref-40" hwp:rev-id="xref-ref-40-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.40" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-40"><string-name name-style="western" hwp:sortable="Moreno M."><surname>Moreno</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal>, <year>2014</year>. <article-title hwp:id="article-title-41">Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE</article-title>. <source hwp:id="source-40">J Neurosci</source>. <volume>34</volume>, <fpage>8175</fpage>â<lpage>85</lpage>.</citation></ref><ref id="c41" hwp:id="ref-41" hwp:rev-id="xref-ref-41-1 xref-ref-41-2"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.41" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-41"><string-name name-style="western" hwp:sortable="Mundt S."><surname>Mundt</surname>, <given-names>S.</given-names></string-name>, <etal>et al.</etal>, <year>2019</year>. <article-title hwp:id="article-title-42">Conventional DCs sample and present myelin antigens in the healthy CNS and allow parenchymal T cell entry to initiate neuroinflammation</article-title>. <source hwp:id="source-41">Sci Immunol</source>. <volume>4</volume>.</citation></ref><ref id="c42" hwp:id="ref-42" hwp:rev-id="xref-ref-42-1 xref-ref-42-2"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.42" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-42"><string-name name-style="western" hwp:sortable="Piccio L."><surname>Piccio</surname>, <given-names>L.</given-names></string-name>, <etal>et al.</etal>, <year>2007</year>. <article-title hwp:id="article-title-43">Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis</article-title>. <source hwp:id="source-42">Eur J Immunol</source>. <volume>37</volume>, <fpage>1290</fpage>â<lpage>301</lpage>.</citation></ref><ref id="c43" hwp:id="ref-43" hwp:rev-id="xref-ref-43-1 xref-ref-43-2"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.43" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-43"><string-name name-style="western" hwp:sortable="Prodinger C."><surname>Prodinger</surname>, <given-names>C.</given-names></string-name>, <etal>et al.</etal>, <year>2011</year>. <article-title hwp:id="article-title-44">CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system</article-title>. <source hwp:id="source-43">Acta Neuropathol</source>. <volume>121</volume>, <fpage>445</fpage>â<lpage>58</lpage>.</citation></ref><ref id="c44" hwp:id="ref-44" hwp:rev-id="xref-ref-44-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.44" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-44"><string-name name-style="western" hwp:sortable="Romme Christensen J."><surname>Romme Christensen</surname>, <given-names>J.</given-names></string-name>, <etal>et al.</etal>, <year>2013</year>. <article-title hwp:id="article-title-45">Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17-and activated B-cells and correlates with progression</article-title>. <source hwp:id="source-44">PLoS One</source>. <volume>8</volume>, <fpage>e57820</fpage>.</citation></ref><ref id="c45" hwp:id="ref-45" hwp:rev-id="xref-ref-45-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.45" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-45"><string-name name-style="western" hwp:sortable="Sato-Hashimoto M."><surname>Sato-Hashimoto</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal>, <year>2019</year>. <article-title hwp:id="article-title-46">Microglial SIRPalpha regulates the emergence of CD11c(+) microglia and demyelination damage in white matter</article-title>. <source hwp:id="source-45">Elife</source>. <volume>8</volume>.</citation></ref><ref id="c46" hwp:id="ref-46" hwp:rev-id="xref-ref-46-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.46" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-46"><string-name name-style="western" hwp:sortable="Serafini B."><surname>Serafini</surname>, <given-names>B.</given-names></string-name>, <etal>et al.</etal>, <year>2000</year>. <article-title hwp:id="article-title-47">Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis</article-title>. <source hwp:id="source-46">Am J Pathol</source>. <volume>157</volume>, <fpage>1991</fpage>â<lpage>2002</lpage>.</citation></ref><ref id="c47" hwp:id="ref-47" hwp:rev-id="xref-ref-47-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.47" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-47"><string-name name-style="western" hwp:sortable="Sorge R. E."><surname>Sorge</surname>, <given-names>R. E.</given-names></string-name>, <etal>et al.</etal>, <year>2015</year>. <article-title hwp:id="article-title-48">Different immune cells mediate mechanical pain hypersensitivity in male and female mice</article-title>. <source hwp:id="source-47">Nat Neurosci</source>. <volume>18</volume>, <fpage>1081</fpage>â<lpage>3</lpage>.</citation></ref><ref id="c48" hwp:id="ref-48" hwp:rev-id="xref-ref-48-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.48" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-48"><string-name name-style="western" hwp:sortable="Tanabe S."><surname>Tanabe</surname>, <given-names>S.</given-names></string-name>, <etal>et al.</etal>, <year>2019</year>. <article-title hwp:id="article-title-49">Microglia suppress the secondary progression of autoimmune encephalomyelitis</article-title>. <source hwp:id="source-48">Glia</source>. <volume>67</volume>, <fpage>1694</fpage>â<lpage>1704</lpage>.</citation></ref><ref id="c49" hwp:id="ref-49" hwp:rev-id="xref-ref-49-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.49" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-49"><string-name name-style="western" hwp:sortable="Taves S."><surname>Taves</surname>, <given-names>S.</given-names></string-name>, <etal>et al.</etal>, <year>2016</year>. <article-title hwp:id="article-title-50">Spinal inhibition of p38 MAP kinase reduces inflammatory and neuropathic pain in male but not female mice: Sex-dependent microglial signaling in the spinal cord</article-title>. <source hwp:id="source-49">Brain Behav Immun</source>. <volume>55</volume>, <fpage>70</fpage>â<lpage>81</lpage>.</citation></ref><ref id="c50" hwp:id="ref-50" hwp:rev-id="xref-ref-50-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.50" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-50"><string-name name-style="western" hwp:sortable="Wlodarczyk A."><surname>Wlodarczyk</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal>, <year>2018</year>. <article-title hwp:id="article-title-51">CSF1R Stimulation Promotes Increased Neuroprotection by CD11c+ Microglia in EAE</article-title>. <source hwp:id="source-50">Front Cell Neurosci</source>. <volume>12</volume>, <fpage>523</fpage>.</citation></ref><ref id="c51" hwp:id="ref-51" hwp:rev-id="xref-ref-51-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.51" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-51"><string-name name-style="western" hwp:sortable="Wlodarczyk A."><surname>Wlodarczyk</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal>, <year>2015</year>. <article-title hwp:id="article-title-52">Pathologic and Protective Roles for Microglial Subsets and Bone Marrow-and Blood-Derived Myeloid Cells in Central Nervous System Inflammation</article-title>. <source hwp:id="source-51">Front Immunol</source>. <volume>6</volume>, <fpage>463</fpage>.</citation></ref><ref id="c52" hwp:id="ref-52" hwp:rev-id="xref-ref-52-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.52" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-52"><string-name name-style="western" hwp:sortable="Wlodarczyk A."><surname>Wlodarczyk</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal>, <year>2017</year>. <article-title hwp:id="article-title-53">A novel microglial subset plays a key role in myelinogenesis in developing brain</article-title>. <source hwp:id="source-52">EMBO J</source>. <volume>36</volume>, <fpage>3292</fpage>â<lpage>3308</lpage>.</citation></ref><ref id="c53" hwp:id="ref-53" hwp:rev-id="xref-ref-53-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.53" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-53"><string-name name-style="western" hwp:sortable="Zarubin T."><surname>Zarubin</surname>, <given-names>T.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Han J."><surname>Han</surname>, <given-names>J.</given-names></string-name>, <year>2005</year>. <article-title hwp:id="article-title-54">Activation and signaling of the p38 MAP kinase pathway</article-title>. <source hwp:id="source-53">Cell Res</source>. <volume>15</volume>, <fpage>11</fpage>â<lpage>8</lpage>.</citation></ref><ref id="c54" hwp:id="ref-54" hwp:rev-id="xref-ref-54-1"><citation publication-type="journal" citation-type="journal" ref:id="396036v4.54" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-54"><string-name name-style="western" hwp:sortable="Zhang T."><surname>Zhang</surname>, <given-names>T.</given-names></string-name>, <etal>et al.</etal>, <year>2015</year>. <article-title hwp:id="article-title-55">Beta-interferon exposure and onset of secondary progressive multiple sclerosis</article-title>. <source hwp:id="source-54">Eur J Neurol</source>. <volume>22</volume>, <fpage>990</fpage>â<lpage>1000</lpage>.</citation></ref></ref-list></back></article>
